Professional Seasonal Analysis for Trading

Iovance Biotherapeutics, Inc. - Common Stock (IOVA)

Seasonality Analysis

Stocks 16 Years Analyzed

Iovance Biotherapeutics, Inc. - Common Stock Annual Seasonality Statistics

30.88%
Avg Annual Return
44.4%
Avg Monthly Win Rate
6/12
Positive Months
16
Years Analyzed

Iovance Biotherapeutics, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -3.51%
25%
Very Weak
February 11.81%
63%
Strong
March -3.14%
25%
Very Weak
April WORST -5.29%
38%
Very Weak
May 0.72%
40%
Weak
June 2.73%
40%
Weak
July BEST 21.04%
73%
Very Strong
August -4.60%
40%
Weak
September -2.39%
27%
Very Weak
October -4.35%
31%
Very Weak
November 11.98%
69%
Strong
December 5.89%
63%
Strong

Iovance Biotherapeutics, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
44.51
Historical Avg Position
41.29
Deviation
+3.22
Performance
On Track

Iovance Biotherapeutics, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for IOVA with overlay patterns, custom date ranges, and more.

Create Free Account

Iovance Biotherapeutics, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Iovance Biotherapeutics, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for IOVA across multiple timeframes.

Create Free Account

About Iovance Biotherapeutics, Inc. - Common Stock (IOVA) Seasonality

Iovance Biotherapeutics, Inc. - Common Stock (IOVA) has been analyzed using 16 years of historical data to identify seasonal patterns. Classified under Stocks, Iovance Biotherapeutics, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Iovance Biotherapeutics, Inc. - Common Stock is historically July, with an average return of 21.04% and a win rate of 73%. Conversely, April tends to be the weakest month, averaging -5.29% return.

Looking at the full calendar year, Iovance Biotherapeutics, Inc. - Common Stock has an average annual return of 30.88% with an overall monthly win rate of 44.4%. Out of 12 months, 6 typically show positive average returns.

The seasonal pattern for Iovance Biotherapeutics, Inc. - Common Stock has a consistency score of 40.3 (Poor), based on 17 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Iovance Biotherapeutics, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Iovance Biotherapeutics, Inc. - Common Stock (IOVA)?

Historically, July has been the best month for Iovance Biotherapeutics, Inc. - Common Stock, with an average return of 21.04% and a win rate of 73%. However, past performance does not guarantee future results.

What is the worst month for Iovance Biotherapeutics, Inc. - Common Stock (IOVA)?

Based on historical data, April has been the weakest month for Iovance Biotherapeutics, Inc. - Common Stock, with an average return of -5.29%. This is a historical observation and does not guarantee future results.

How reliable is IOVA seasonality data?

The seasonality analysis for Iovance Biotherapeutics, Inc. - Common Stock is based on 16 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Iovance Biotherapeutics, Inc. - Common Stock seasonality in my trading?

Use Iovance Biotherapeutics, Inc. - Common Stock (IOVA) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.